The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study.

Amrein, P C; Poulin, R F; Coleman, M; Richards, F; Weil, M; Kennedy, B J; Carey, R W; Green, M R; Holland, J F; Weinberg, V

Amrein, P C; Poulin, R F; Coleman, M; Richards, F; Weil, M; Kennedy, B J; Carey, R W; Green, M R; Holland, J F; Weinberg, V.

Am J Clin Oncol ; 7(3): 269-71, 1984 Jun.

Article in En | MEDLINE | ID: mdl-6547269

Subject(s)

Aminoacridines/therapeutic use; Antineoplastic Agents/therapeutic use; Melanoma/drug therapy; Adult; Aged; Aminoacridines/adverse effects; Amsacrine; Antineoplastic Agents/adverse effects; Drug Evaluation; Female; Humans; Leukopenia/chemically induced; Lung Neoplasms/secondary; Lymphatic Metastasis; Male; Middle Aged; Nausea/chemically induced; Skin Neoplasms/secondary; Thrombocytopenia/chemically induced

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aminoacridines / Melanoma / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 1984 Type: Article

Search on Google

XML

PubMed Links